Overall, these findings extend the understanding of environmental pollutant-induced metabolic disorders and identify the hepatic AhR–PAI-1 axis as a potential therapeutic target for obesity and related metabolic diseases. The gene discussed is AHR; the disease is Other metabolic disease.